Contribution of personalized Cyclin D1 genotype to triple negative breast cancer risk
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2211-8039
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Contribution of personalized Cyclin D1 genotype to triple negative breast cancer risk ; volume:4 ; number:1 ; day:27 ; month:8 ; year:2014 ; pages:1-4 ; date:3.2014
Biomedicine ; 4, Heft 1 (27.8.2014), 1-4, 3.2014
- Urheber
-
Liu, Liang-Chih
Su, Chen-Hsien
Wang, Hwei-Chung
Chang, Wen-Shin
Tsai, Chia-Wen
Maa, Ming-Chei
Tsai, Chang-Hai
Tsai, Fuu-Jen
Bau, Da-Tian
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.7603/s40681-014-0003-4
- URN
-
urn:nbn:de:101:1-2021061721184516159234
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liu, Liang-Chih
- Su, Chen-Hsien
- Wang, Hwei-Chung
- Chang, Wen-Shin
- Tsai, Chia-Wen
- Maa, Ming-Chei
- Tsai, Chang-Hai
- Tsai, Fuu-Jen
- Bau, Da-Tian
- SpringerLink (Online service)
Ähnliche Objekte (12)
Contribution of cyclin G2 to the cell cycle inhibitory effects of cancer therapeutics
Contribution of parasite and host genotype to immunopathology of schistosome infections
Cyclin-dependent kinases
Cyclin E expression is associated with high levels of replication stress in triple-negative breast cancer
Charakterisierung von Cyclin L2 : ein neuer Vertreter der Cyclin-Familie
Cyclin K and cyclin D1b are oncogenic in myeloma cells
Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients
Expression der Zellzyklusregulatoren Cyclin D1 und Cyclin D3 in Mantelzell-Lymphomen
Personalized signaling models for personalized treatments
Personalized signaling models for personalized treatments
Interpreting changes in measles genotype: the contribution of chance, migration and vaccine coverage
Expression der Zellzyklusregulatorgene Cyclin A, Cyclin B1, p16 und cdk2 beim Ovarialkarzinom
Contribution of cyclin G2 to the cell cycle inhibitory effects of cancer therapeutics
Contribution of parasite and host genotype to immunopathology of schistosome infections
Cyclin-dependent kinases
Cyclin E expression is associated with high levels of replication stress in triple-negative breast cancer
Charakterisierung von Cyclin L2 : ein neuer Vertreter der Cyclin-Familie
Cyclin K and cyclin D1b are oncogenic in myeloma cells
Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients
Expression der Zellzyklusregulatoren Cyclin D1 und Cyclin D3 in Mantelzell-Lymphomen
Personalized signaling models for personalized treatments
Personalized signaling models for personalized treatments
Interpreting changes in measles genotype: the contribution of chance, migration and vaccine coverage
Expression der Zellzyklusregulatorgene Cyclin A, Cyclin B1, p16 und cdk2 beim Ovarialkarzinom
Contribution of cyclin G2 to the cell cycle inhibitory effects of cancer therapeutics
Contribution of parasite and host genotype to immunopathology of schistosome infections
Cyclin-dependent kinases
Cyclin E expression is associated with high levels of replication stress in triple-negative breast cancer
Charakterisierung von Cyclin L2 : ein neuer Vertreter der Cyclin-Familie
Cyclin K and cyclin D1b are oncogenic in myeloma cells
Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients
Expression der Zellzyklusregulatoren Cyclin D1 und Cyclin D3 in Mantelzell-Lymphomen
Personalized signaling models for personalized treatments
Personalized signaling models for personalized treatments
Interpreting changes in measles genotype: the contribution of chance, migration and vaccine coverage